Complete radiographic response to immunotherapy in a patient with metastatic anaplastic thyroid cancer – a case report and review of the literature - Scorecard - MDSpire

Complete radiographic response to immunotherapy in a patient with metastatic anaplastic thyroid cancer – a case report and review of the literature

  • By

  • Monika Mierzejewska

  • Lin Akily

  • William Karlsen

  • Jacek Teodorczyk

  • Bartłomiej Tomasik

  • Jacek Rutkowski

  • Piotr Wiśniewski

  • Maciej Śledziński

  • Karolina Markiet

  • Jolanta Szade

  • Renata Zaucha

  • Wojciech Cytawa

  • June 2, 2026

  • 0 min

Share

Clinical Scorecard: Successful Radiographic Resolution Following Immunotherapy in a Patient with Metastatic Anaplastic Thyroid Carcinoma: A Case Study and Literature Review

At a Glance

CategoryDetail
Condition
Key MechanismsHigh PD-L1 expression leading to treatment with immune checkpoint inhibitor (nivolumab) - ensure this is directly sourced.
Target Population
Care Setting

Key Highlights

  • Remove phrases indicating treatment success or survival benefits unless directly quoted from the source.

Guideline-Based Recommendations

Diagnosis

    Management

    • C
    • l
    • a
    • r
    • i
    • f
    • y
    • t
    • h
    • a
    • t
    • o
    • f
    • f
    • -
    • l
    • a
    • b
    • e
    • l
    • u
    • s
    • e
    • o
    • f
    • n
    • i
    • v
    • o
    • l
    • u
    • m
    • a
    • b
    • i
    • s
    • b
    • a
    • s
    • e
    • d
    • o
    • n
    • t
    • h
    • e
    • c
    • a
    • s
    • e
    • s
    • t
    • u
    • d
    • y
    • f
    • i
    • n
    • d
    • i
    • n
    • g
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        76-year-old female with recurrent metastatic ATC

        Nivolumab administered at 240 mg every two weeks, with significant clinical improvement noted

        Clinical Best Practices

        • Remove any editorial language and ensure practices are strictly based on the source.

        Related Resources & Content

        Original Source(s)

        Related Content